IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Astrazeneca Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 860827ae3efa0ec8
Drug Cima Aemps Name: IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1181322002IP
Holder Company Name: Astrazeneca Ab
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/astrazeneca-ab
Authorization Date: 2020-11-03
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 50 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Astrazeneca Ab
Company Detail Path: /organization/astrazeneca-ab

DURVALUMAB

120 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 3, 2020

Approval ID

860827ae3efa0ec8

Type

Standard